From the labto the hospital

Translational Research in Cancer in Children and Teenagers

Recerca translacional en càncer en la infància i l’adolescència a Vall d'Hebron Institut de Recerca

Rhabdomyosarcoma and neuroblastoma are high risk tumours in paediatrics, with a survival rate below 30%. The group is focusing on researching the best treatment therapies for this type of cancer in paediatrics.

Description

Focused on childhood cancer, the group is made up of clinical and basic researchers, whose aim is to discover new therapeutic targets and develop new treatments by using animal models.

Specifically, they are working on rhabdomyosarcoma and neuroblastoma, two types of high risk tumours in paediatrics. This type of cancer has many side effects in survivors as a consequence of aggressive treatments. The group is therefore also working on new alternative therapies to improve safety and success.

Visit the research group’s page

Healthcare specialisations
Teaching units
Related professionals
Dra. Soledad
Gallego Melcón
Translational Research into Cancer in Childhood and Adolescence
Head of Department
Paediatric Oncology and Haematology
Dr. Josep
Roma Castanyer
Translational Research into Cancer in Childhood and Adolescence
Dr. Miguel Francisco
Segura Ginard
Translational Research into Cancer in Childhood and Adolescence
Dra. Patricia
Zarzosa Martínez
Translational Research into Cancer in Childhood and Adolescence
Dra. Natalia
Navarro Barea
Translational Research into Cancer in Childhood and Adolescence
Dr. Marc
Masanas Jimenez
Translational Research into Cancer in Childhood and Adolescence
Dra. Irina
Giralt Buch
Translational Research into Cancer in Childhood and Adolescence
 
Noticies y activitats relacionades